On May 16, 2018, Medtronic and Siemens co-sponsored and event to bring together stakeholders from industry and FDA to discuss Design Excellence and the role of modeling and simulation to advance medical devices
During the last 10 years the European Medicines Agency (EMA) organized a number of workshops on mode...
This presentation summarizes the modeling and simulation efforts at FDA, with an emphasis on the rev...
Presentation for:<div><br></div><div><b>Avicenna Alliance & EFGCP: "Modelling a Policy Framework for...
This presentation was delivered as Keynote at the 2018 NAFEMS Conference on Analysis and Simulation ...
This presentation was delivered to members of the European Parliament and some members of the Europe...
This presentation was delivered during the General Session at the Science in the Age of Experience C...
These slides were presented as part of the FDA Grand Rounds on August 9, 2018.FDA recognizes the pub...
Medical-product development has become increasingly challenging and resource-intensive. In 2004, the...
<p>The upcoming publication of the new ASME Standard V&V 40 -- Assessing Credibility of Computationa...
With In Silico offering an understanding of complexity on a scale never before known in human histo...
<p>FDA acknowledges the benefits to public health provided by modeling and simulation, such as those...
This presentation was made at Design of Medical Devices conference 2022, in the session entitled "Ex...
Goal: This annual medical device conference, now in its 13th year, provides attendees with 2 days of...
This presentation was shared with colleagues at the 2018 VPH Institute Conference that took place in...
This presentation was delivered at the 3rd Annual BMES/FDA Frontiers in Medical Devices Conference. ...
During the last 10 years the European Medicines Agency (EMA) organized a number of workshops on mode...
This presentation summarizes the modeling and simulation efforts at FDA, with an emphasis on the rev...
Presentation for:<div><br></div><div><b>Avicenna Alliance & EFGCP: "Modelling a Policy Framework for...
This presentation was delivered as Keynote at the 2018 NAFEMS Conference on Analysis and Simulation ...
This presentation was delivered to members of the European Parliament and some members of the Europe...
This presentation was delivered during the General Session at the Science in the Age of Experience C...
These slides were presented as part of the FDA Grand Rounds on August 9, 2018.FDA recognizes the pub...
Medical-product development has become increasingly challenging and resource-intensive. In 2004, the...
<p>The upcoming publication of the new ASME Standard V&V 40 -- Assessing Credibility of Computationa...
With In Silico offering an understanding of complexity on a scale never before known in human histo...
<p>FDA acknowledges the benefits to public health provided by modeling and simulation, such as those...
This presentation was made at Design of Medical Devices conference 2022, in the session entitled "Ex...
Goal: This annual medical device conference, now in its 13th year, provides attendees with 2 days of...
This presentation was shared with colleagues at the 2018 VPH Institute Conference that took place in...
This presentation was delivered at the 3rd Annual BMES/FDA Frontiers in Medical Devices Conference. ...
During the last 10 years the European Medicines Agency (EMA) organized a number of workshops on mode...
This presentation summarizes the modeling and simulation efforts at FDA, with an emphasis on the rev...
Presentation for:<div><br></div><div><b>Avicenna Alliance & EFGCP: "Modelling a Policy Framework for...